% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Minol:875339,
author = {Minol, Jan-Philipp and Dimitrova, Vanessa and Petrov,
Georgi and Langner, Robert and Boeken, Udo and Rellecke,
Philipp and Aubin, Hug and Kamiya, Hiroyuki and Sixt,
Stephan and Huhn, Ragnar and Sugimura, Yukiharu and Albert,
Alexander and Lichtenberg, Artur and Akhyari, Payam},
title = {{T}he age-adjusted {C}harlson comorbidity index in
minimally invasive mitral valve surgery},
journal = {European journal of cardio-thoracic surgery},
volume = {56},
number = {6},
issn = {1873-734X},
address = {Oxford},
publisher = {Oxford Univ. Press},
reportid = {FZJ-2020-01962},
pages = {1124 - 1130},
year = {2019},
abstract = {OBJECTIVESMitral valve repair is the preferred method used
to address mitral valve regurgitation, whereas transcatheter
mitral valve repair is recommended for high-risk patients.
We evaluated the risk-predictive value of the age-adjusted
Charlson comorbidity index (aa-CCI) in the setting of
minimally invasive mitral valve surgery.METHODSThe
perioperative course and 1-year follow-up of 537 patients
who underwent isolated or combined minimally invasive mitral
valve surgery were evaluated for 1-year mortality as the
primary end point and other adverse events. The predictive
values of the EuroSCORE II and STS score were compared to
that of the aa-CCI by a comparative analysis of receiver
operating characteristic curves. Restricted cubic splines
were applied to find optimal aa-CCI cut-off values for the
increased likelihood of experiencing the predefined adverse
end points. Consequently, the perioperative course and
postoperative outcome of the aa-CCI ≥8 patients and the
remainder of the sample were analysed.RESULTSThe predictive
value of the aa-CCI does not significantly differ from those
of the EuroSCORE II or STS score. Patients with an aa-CCI
≥8 were identified as a subgroup with a significant
increase of mortality and other adverse
events.CONCLUSIONSThe aa-CCI displays a suitable predictive
ability for patients undergoing minimally invasive mitral
valve surgery. In particular, multimorbid or frail patients
may benefit from the extension of the objectively assessed
parameters, in addition to the STS score or EuroSCORE II.
Patients with an aa-CCI ≥8 have a very high surgical risk
and should receive very careful attention.},
cin = {INM-7},
ddc = {610},
cid = {I:(DE-Juel1)INM-7-20090406},
pnm = {572 - (Dys-)function and Plasticity (POF3-572)},
pid = {G:(DE-HGF)POF3-572},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:31501891},
UT = {WOS:000501730300014},
doi = {10.1093/ejcts/ezz240},
url = {https://juser.fz-juelich.de/record/875339},
}